- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Americans for Safe Access’s Patient Focused Certification standards for medical marijuana accepted as foundational recommendations
Last week, global standards organization ASTM International and the American Herbal Products Association (AHPA) announced that they will develop standards for the cannabis industry. Under the agreement, ASTM International will coordinate standards development activities for the cannabis industry, while AHPA will gain recognition for its technical contributions and regulatory recommendations. The AHPA standards are the basis of the Patient Focused Certification (PFC) program that is used internationally to assess regulatory compliance at medical cannabis operations, and to educate the medical cannabis industry and program administrators.
This news comes in advance of ASTM International's first ever cannabis committee happening June 11th and 12th. The event is part of a larger "committee week" event with about 25 committees and 1,500 attendees at the Sheraton Centre Toronto in Ontario, Canada.
“The ASTM International and AHPA partnership is a groundbreaking development for cannabis industry professionals and patients everywhere,” said Dr. Jahan Marcu Chief Science Officer of ASA and SubCommittee Chairman of the ASTM D37 Cannabis Committee. “This is great news for our Patient Focused Certification (PFC) clients, as the PFC program is fueled by the AHPA guidance documents, which are being used as the foundational documents for these international standards. PFC certified organizations are on the right track to meet international regulations. Further, the development and maintenance of international standards and guidance for the knowledge and skill requirements for the education, training, assessment and credentialing of personnel is an urgent, priority for patients, and the cannabis industry.
In addition, through a license agreement, the new committee's standards will note when AHPA contributed technical expertise or content from one of its "Recommendations for Regulators”